الفهرس 
PREDICTION OF MALIGNANCY IN ADNEXAL MASSESOnly 14 pages are availabe for public view
 |  | from | 160 |  |  |
| | | from | 160 | | |
Abstract
Ovarian cancer is one of the most important leading cause of cancer deaths among women.
Ovarian cancer is the second most commonly diagnosed gynecologic malignancy in the United States, it is also the most deadly because over 70% of women are diagnosed with advanced stage disease when cure rates are only 20-30% early stage ovarian cancer has an excellent prognosis of treated.
In recent years, several articles have been published about mesothelin as a new tumor marker used in diagnosis of malignant ovarian lesions.
In our study we evaluate the ability of serum mesothelin concentration to differentiate between benign and malignant ovarian masses.
The present study was carried out at Ain shams University Maternity Hospital, Gynecologic Hospitalized patients during the period from June/2011 till April 2012. The study included a total of 96 women who were of different ages (20-70 years) with pelvic or pelvi-abdominal mass with established diagnosis of an ovarian mass.